Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.5675
-0.0010 (-0.18%)
At close: Apr 1, 2026, 4:00 PM EDT
0.5700
+0.0025 (0.44%)
After-hours: Apr 1, 2026, 4:43 PM EDT
Cellyan Biotechnology Market Cap
Cellyan Biotechnology has a market cap or net worth of $13.34 million as of April 1, 2026. Its market cap has increased by 11.23% in one year.
Market Cap
13.34M
Enterprise Value
12.95M
1-Year Change
11.23%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since the IPO on January 15, 2025, Cellyan Biotechnology's market cap has decreased from $44.00M to $13.34M, a decrease of -69.69%. That is a compound annual growth rate of -62.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 13.36M | 47.32% |
| Dec 31, 2025 | 9.07M | -79.39% |
| Jan 15, 2025 | 44.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 823.03B |
| Johnson & Johnson | 588.76B |
| AbbVie | 384.69B |
| AstraZeneca | 300.86B |
| Cocrystal Pharma | 13.92M |
| Hoth Therapeutics | 13.66M |
| BioAtla | 13.34M |
| BioCardia | 13.24M |